Deltec Asset Management LLC acquired a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, Holdings Channel reports. The firm acquired 4,000 shares of the company’s stock, valued at approximately $591,000.

A number of other hedge funds also recently modified their holdings of TMO. Wellington Management Group LLP raised its stake in shares of Thermo Fisher Scientific by 26.0% in the first quarter. Wellington Management Group LLP now owns 6,135,669 shares of the company’s stock valued at $868,749,000 after buying an additional 1,267,967 shares during the period. Primecap Management Co. CA raised its stake in shares of Thermo Fisher Scientific by 0.7% in the first quarter. Primecap Management Co. CA now owns 5,439,360 shares of the company’s stock valued at $770,159,000 after buying an additional 39,470 shares during the period. BlackRock Fund Advisors raised its stake in shares of Thermo Fisher Scientific by 1.6% in the first quarter. BlackRock Fund Advisors now owns 5,425,770 shares of the company’s stock valued at $768,235,000 after buying an additional 83,861 shares during the period. BlackRock Group LTD raised its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. BlackRock Group LTD now owns 3,432,864 shares of the company’s stock valued at $486,060,000 after buying an additional 18,153 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 1.3% in the first quarter. Geode Capital Management LLC now owns 3,120,308 shares of the company’s stock valued at $440,879,000 after buying an additional 40,214 shares during the period. Hedge funds and other institutional investors own 87.38% of the company’s stock.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up 1.44% during midday trading on Thursday, hitting $157.66. The stock had a trading volume of 1,599,025 shares. The company has a 50-day moving average price of $152.66 and a 200-day moving average price of $149.08. The company has a market cap of $62.16 billion, a price-to-earnings ratio of 31.54 and a beta of 1.00. Thermo Fisher Scientific Inc. has a 12-month low of $117.10 and a 12-month high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Thursday, July 28th. The company reported $2.03 EPS for the quarter, beating the consensus estimate of $2.01 by $0.02. The business had revenue of $4.54 billion for the quarter, compared to the consensus estimate of $4.50 billion. Thermo Fisher Scientific had a return on equity of 14.70% and a net margin of 11.35%. The company’s revenue was up 6.2% on a year-over-year basis. During the same period last year, the business posted $1.84 EPS. Equities analysts anticipate that Thermo Fisher Scientific Inc. will post $8.16 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.38%. Thermo Fisher Scientific’s payout ratio is currently 12.02%.

TMO has been the topic of a number of recent research reports. Mizuho boosted their price target on shares of Thermo Fisher Scientific from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Friday, May 27th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 price target on the stock in a research note on Monday, August 1st. Cleveland Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Wednesday, July 6th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Thermo Fisher Scientific in a research note on Thursday. They set an “overweight” rating and a $180.00 price target on the stock. Three research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $160.79.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 30,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $148.85, for a total transaction of $4,465,500.00. Following the sale, the chief executive officer now directly owns 350,998 shares in the company, valued at approximately $52,246,052.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 5th. The stock was sold at an average price of $147.69, for a total value of $2,953,800.00. Following the sale, the chief executive officer now owns 340,998 shares in the company, valued at $50,361,994.62. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.